M MOBOCERTINIB (is an active metabolite) 
| MOBOCERTINIB | ANTINEOPLASTIC KINASE INHIBITOR TREATMENT OF NSCLC WITH EGFR EXON 20 INSERTION MUTATIONS | - | PPB 99.5 PERCENT Cl 149 LITER / HOUR HT 24 HOUR | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) (MUTATED) | More at DrugCentral | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |